SEC Filings for Actinium Pharmaceuticals Inc. (Delaware) (ATNM)

$ 0.2299   -0.0012 (-0.52%) Volume: 26.83k 9:58 AM EDT 17-Sep-2019
Filing Type:
Form TypeForm DescriptionPagesDateView
10-QQuarterly report with a continuing view of a company's financial position4608/09/2019
4Statement of changes in beneficial ownership of securities107/16/2019
4Statement of changes in beneficial ownership of securities107/16/2019
4Statement of changes in beneficial ownership of securities107/16/2019
4Statement of changes in beneficial ownership of securities107/16/2019
4Statement of changes in beneficial ownership of securities107/16/2019
4Statement of changes in beneficial ownership of securities107/16/2019
4Statement of changes in beneficial ownership of securities107/16/2019
4Statement of changes in beneficial ownership of securities107/16/2019
4Statement of changes in beneficial ownership of securities107/16/2019
8-KReport of unscheduled material events or corporate changes.306/07/2019
10-QQuarterly report with a continuing view of a company's financial position4405/10/2019
S-8Securities offered to employees under employee benefit plans1005/10/2019
8-KReport of unscheduled material events or corporate changes.7504/18/2019
424B5Prospectus filed under Rule 424(b)(5)6204/18/2019
<<
First
<
Prev
123456789101112131415